Alivio Therapeutics has a total of 28 patents globally, out of which 6 have been granted. Of these 28 patents, more than 85% patents are active. Japan is where Alivio Therapeutics has filed the maximum number of patents, followed by Australia and USA. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Alivio Therapeutics.
Alivio Therapeutics was founded in 2016. Alivio Therapeutics is developing a novel approach to treating inflammatory illnesses by precisely modifying the immune system.
Do read about some of the most popular patents of Alivio Therapeutics which have been covered by us in this article and also you can find Alivio Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alivio Therapeutics patent portfolio.
How many patents does Alivio Therapeutics have?
Alivio Therapeutics has a total of 28 patents globally. These patents belong to 3 unique patent families. Out of 28 patents, 24 patents are active.
How Many Patents did Alivio Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Alivio Therapeutics Applications Filed | Alivio Therapeutics Patents Granted |
| 2023 | 3 | 3 |
| 2022 | 4 | 1 |
| 2021 | 2 | 2 |
| 2020 | 1 | – |
| 2019 | 12 | – |
| 2018 | 6 | – |
How many Alivio Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Alivio Therapeutics File in Different Countries?
Countries in which Alivio Therapeutics Filed Patents
| Country | Patent |
| Japan | 7 |
| Australia | 5 |
| United States Of America | 4 |
| Canada | 3 |
| Europe | 3 |
| Hong Kong (S.A.R.) | 2 |
| Israel | 1 |
Where are Research Centers of Alivio Therapeutics Patents Located?
The Research Centers of AlivioTherapeutics Patents is the United States of America.
What Percentage of Alivio Therapeutics US Patent Applications Were Granted?
Alivio Therapeutics (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Alivio Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Alivio Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Womble Bond Dickinson Us Llp | 4 | 100% |
List of Alivio Therapeutics patents
| Publication Number | Title |
| US10881745B2 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
| US20210196836A1 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
| US20200114010A1 | Non-Injectable Hydrogel Formulations For Smart Release |
| EP3863602A1 | Non-Injectable Hydrogel Formulations For Smart Release |
| EP3773478A1 | Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof |
| EP3621594A1 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
| AU2021240143B2 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
| AU2019247375B2 | Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof |
| AU2018266131B2 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
| AU2022235578A1 | Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof |
| AU2019357859A1 | Non-Injectable Hydrogel Formulations For Smart Release |
| CA3113948A1 | Non-Injectable Hydrogel Formulations For Smart Release |
| CA3096745A1 | Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof |
| CA3061480A1 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
| JP7323608B2 | Non-Injectable Hydrogel Formulation For Smart Release |
| JP7211974B2 | Formulation Of Nanostructured Gels For Increased Drug Loading And Adhesion |
| JP2023041861A5 | Formulation Of Nanostructured Gels For Increased Drug Loading And Adhesion |
| JP2023133446A | Self-Assembling Gels And Methods For Their Production For Controlled Delivery Of Biologics |
| JP2023101656A | Non-Injectable Hydrogel Formulations For Smart Release |
| JP2022103299A5 | Formulation Of Nanostructured Gels For Increased Drug Loading And Adhesion |
| JPWO2019195546A5 | Self-Assembled Gel For Controlled Delivery Of Biologics And Method Of Making Same |
| HK40065558A | Non-Injectable Hydrogel Formulations For Smart Release |
| HK40060017A | Non-Injectable Hydrogel Formulations For Smart Release |
| IL282061A | Non-Injectable Hydrogel Formulations For Smart Release |
| US20190307885A1 | Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof |
| WO2020076453A1 | Non-Injectable Hydrogel Formulations For Smart Release |
| WO2019195546A1 | Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof |
| WO2018208822A1 | Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion |
What are Alivio Therapeutics key innovation segments?
What Technologies are Covered by Alivio Therapeutics?
The chart below distributes patents filed by Alivio Therapeutics